AdaptHealth (AHCO) Gets a Buy from Truist Financial

In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on AdaptHealth, with a price target of $13.00.

Claim 50% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

According to TipRanks, S Macdonald is a 5-star analyst with an average return of 11.5% and a 59.32% success rate. S Macdonald covers the Healthcare sector, focusing on stocks such as Centene, Molina Healthcare, and Tenet Healthcare.

In addition to Truist Financial, AdaptHealth also received a Buy from TipRanks – Google’s Google Medical – Devices in a report issued yesterday. However, today, TipRanks – Google downgraded AdaptHealth (NASDAQ: AHCO) to a Hold.

Based on AdaptHealth’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $846.29 million and a GAAP net loss of $102.77 million. In comparison, last year the company earned a revenue of $856.65 million and had a net profit of $50.26 million

Based on the recent corporate insider activity of 20 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of AHCO in relation to earlier this year. Most recently, in December 2025, David Solomon III Williams, a Director at AHCO sold 5,000.00 shares for a total of $47,150.00.